Rankings
▼
Calendar
LGVN FY 2023 Earnings — Longeveron Inc. Revenue & Financial Results | Market Cap Arena
LGVN
Longeveron Inc.
$20M
FY 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$709,000
-42.0% YoY
Gross Profit
$221,000
31.2% margin
Operating Income
-$21M
-2966.0% margin
Net Income
-$21M
-3020.2% margin
EPS (Diluted)
$-10.22
Cash Flow
Operating Cash Flow
-$19M
Free Cash Flow
-$19M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$12M
Total Liabilities
$5M
Stockholders' Equity
$7M
Cash & Equivalents
$5M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$709,000
$1M
-42.0%
Gross Profit
$221,000
$497,000
-55.5%
Operating Income
-$21M
-$18M
-16.5%
Net Income
-$21M
-$19M
-13.7%
← Q4 2022
All Quarters
Q1 2023 →